Codexis (CDXS) Cost of Revenue (2010 - 2026)
Codexis (CDXS) posted quarterly Cost of Revenue of $2.1 million for Q1 2026, down 24.45% year-over-year from $2.7 million in Q1 2025, and up 1.03% quarter-over-quarter from $2.0 million in Q4 2025.
Codexis (CDXS) Cost of Revenue (2010 - 2026) Analysis & Trends
Codexis' Cost of Revenue history runs 17 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Cost of Revenue fell 24.45% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $8.7 million (down 38.79% YoY), while the FY2025 annual figure was $9.3 million, down 42.67% from the prior year.
- Cost of Revenue for Q1 2026 stood at $2.1 million, up from $2.0 million in the prior quarter.
- The five-year high for Cost of Revenue was $11.3 million in Q2 2022, with the low at $2.0 million in Q4 2025.
- The 5-year median for Cost of Revenue is $3.5 million (2024), against an average of $4.6 million.
- The sharpest annual moves came in 2022 and 2023: Cost of Revenue jumped 161.0% in 2022, then plunged 77.02% in 2023.
- Codexis' Cost of Revenue stood at $8.5 million in 2022, then sank by 66.15% to $2.9 million in 2023, then grew by 27.67% to $3.7 million in 2024, then slumped by 44.09% to $2.0 million in 2025, then climbed by 1.03% to $2.1 million in 2026.
- Business Quant data shows CDXS's Cost of Revenue at $2.1 million in Q1 2026, $2.0 million in Q4 2025, and $2.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 489.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 360.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 145.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 93.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 174.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 298.26 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 387.98 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 67.21 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | 3.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.51 Mn |
| Jun 30, 2026 | 3.51 Mn |
| Mar 31, 2026 | 2.06 Mn |
| Mar 31, 2026 | 2.06 Mn |
| Dec 31, 2025 | 2.04 Mn |
| Dec 31, 2025 | 2.04 Mn |
| Sep 30, 2025 | 2.47 Mn |
| Sep 30, 2025 | 2.47 Mn |
| Jun 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | 2.10 Mn |
| Mar 31, 2025 | 2.73 Mn |
| Mar 31, 2025 | 2.73 Mn |
| Dec 31, 2024 | 3.65 Mn |
| Dec 31, 2024 | 3.65 Mn |
| Sep 30, 2024 | 4.32 Mn |
| Sep 30, 2024 | 4.32 Mn |
| Jun 30, 2024 | 3.46 Mn |
| Jun 30, 2024 | 3.46 Mn |
| Mar 31, 2024 | 4.86 Mn |
| Mar 31, 2024 | 4.86 Mn |